TGTX
TG Therapeutics, Inc.
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||
| Capital Expenditures | 214,000 | 45,000 | 0 | 14,000 | 401,000 | 357,000 | 131,000 | 90,000 | 2,000 | 1,399 | 0 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||
| Free Cash Flow | -25.0M | -40.6M | -31.4M | -176.2M | -296.0M | -214.9M | -132.9M | -129.0M | -93.8M | -5.2M | -86,577 |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — |